table of contents - bio · the bio ip counsels committee conferences are must-attend events for the...

The Biotechnology Industry Organization (BIO) is the world’s largest biotechnology association. As a non-profit, our mission is to effectively advocate public policies critical for the success of the biotech community and to convene premier global conferences that propel business activity.

We represent more than 1,100 organizations involved in the research and development of innovative healthcare, agricultural, industrial and environmental products. Our members range from small, entrepreneurial companies developing a first product to Fortune 500 multinationals.

bio.org

TABLE OF CONTENTS

BIO International Convention p. 2

Business Development & Investor p. 4

Food & Agriculture p. 12

Industrial & Environmental p. 18

Intellectual Property p. 20

Sponsorship Information p. 22

—Denotes One-on-One ParterningTM at the conference

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C

onvention Business D

evelopment &

Investor Industrial & Environm

ental Intellectual Property Food &

Agriculture S

ponsorship Info

p. 2 p. 3

Global Branding Opportunities Start at BIOThe BIO International Convention brings together the largest gathering of biotech professionals from around the world—and, for advertisers and sponsors, provides unparalleled brand exposure to a targeted audience.

• 16,500 powerful biotech leaders

• 30% of attendees come from outside the U.S.

• 65 countries represented

• 2,000+ top industry suppliers showcasing the latest technologies in the BIO exhibition

An Influential AudienceThe most powerful companies from all biotech fields send their top executives to get business done at BIO. The BIO One-On-One Partnering™ system helps these frontrunners search for potential business partners and schedule meetings at the convention.

Partnering was a huge success in 2012—

• 3,000+ companies in the BIO One-on-One Partnering™ system

• 25,000+ face-to-face meetings

What’s your BIO? convention.bio.org

“ There is no other event in the biotech industry that is so beneficial for making new, valuable business contacts.” Roland Meisel, PhD Director Business Development, Celonic 2011 BIO International Convention Attendee

Reinforce your brand at BIO. For more info, contact Beth Perkins, [email protected].

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 4 p. 5

The BIO CEO & Investor ConferenceTM is the largest investor conference focused on established and emerging publicly traded biotech companies. The conference presents a broad and unbiased view of investment opportunities and industry trends that is consistent with BIO’s mission to support industry-wide success. bio.org/bioceo

Accelerate Your Pathway to Partnerships in Asia

Tokyo, Japan: January 29-30, 2013

For more info, contact Beth Perkins, [email protected]

Attendees by Region

Conference Size 325+

One-on-One PartneringTM Meetings 1,075+

Japan 38%

Asia18%

US28%

Europe 16%

New York, NY: February 11-12, 2013

Where Biotech’s Elite Engages the Street

For more info, contact Susanna Ling, [email protected]

Associate 10%

Conference Size 1,150+

One-on-One PartneringTM Meetings 1, 300+

Investors Attending 600

Company Presentations 140

Attendees by Title

Executive 36%

Other 7%

Manager 10%

V.P. 11%

Analyst 11%

Director 15%

The BIO Asia International ConferenceTM is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements. bio.org/bioasia

TM

TM

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 6 p. 7

BioEquity EuropeTM is an annual collaborative gathering of corporate and investment communities for European life sciences. The event has become a magnet for financial and pharmaceutical company deal makers. It is the premier venue for biopharma companies looking to attract capital and expand their business development efforts. biocentury.com/conferences

Stockholm, Sweden: May 22-23, 2013

Dedicated to Expanding Capital Markets for Investment in the Life Sciences in Europe


Conference Size 400

Presenting Companies 95+

TM

“Year after year, BioCentury’s Bio€quity Europe program iden-tifies forward-looking themes that biopharma executives and their investors need to be focused on. This annual conference, the unparalleled networking opportunities, and the timely panel discussions serve as a clear reminder that industry stakeholders depend on this gathering to shape their thinking for the year to come.” — Denise Pollard-Knight, PhD

Managing Partner, Phase4 Ventures

Barcelona, Spain: March 11-13, 2013

Where the Global Biotech Industry Comes to Partner BIO-Europe Spring® is the springtime counterpart to BIO-Europe® and continues the tradition of providing life science companies with high caliber partnering opportunities. ebdgroup.com/bes


Conference Size 2,150

Partnering Meetings 11,000+

Licensing Opportunities Posted 2,500+

Companies 1,300

Sr. Mgmt. 44%

Attendees by Seniority

Middle Mgmt./Other 24%

C-Level Executives 32%

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 8 p. 9

Other 3% Services 1%

Accelerate Discovery. Amplify Returns.The BIO Investor ForumTM is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables, therapeutic workshops, company presentations, and One-on-One PartneringTM meetings.bio.org/investorforum

San Francisco, CA: October 8-9, 2013



One-on-One PartneringTM Meetings 875+

Privately Owned Companies 70%

Meetings between Companies and Investors 80%

Companies by Focus

Investor 53%

Biotech33%

Pharma 10%

TM

Maximize Collaborations with India’s Leading Biopharma Innovators The BIO India International ConferenceTM brings together biotechnology and pharmaceutical companies from North America, Europe and Asia to meet and explore business opportunities with India’s emerging biotech sector. ABLE, BIO’s partner in India, brings to the meeting extensive local expertise and its comprehensive network of Indian and Asian biotech and pharmaceutical companies. bio.org/bioindia

FALL 2013




Attendees by Region

India 74%

Other 2%

US13%

Europe 11%

TM

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 10 p. 11

Others: Government, Agencies, Associations, Universities, Press 12%

Building ValueThrough Partnerships

Vienna, Austria: November 4-6, 2013


Conference Size 2,900

Partnering Meetings 14,700+

Companies 1,500+

Countries 48

Attendees by Industry

Finance 5%

Biotech 34%CRO, CMO,

Service, Law, Consulting 28%

Pharma 21%

BIO-EuropeTM is Europe’s largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading deal makers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of the EBD Group, it is regarded as a “must attend” event for the biotech industry. ebdgroup.com/bioeurope

In a City of 23 Million, Find the 3 Connections that MatterThe BIO Convention in ChinaTM is the premier event where Western biopharma executives and investors explore opportunities with China’s emerging biotech sector. The event places industry players from North America, Europe and Asia face-to-face with Chinese biopharma executives, officials and entrepreneurs. bio.org/biochina

Attendees by Region



FALL 2013

For more info, contact John Sloan, [email protected]

China 55%

Asia13%

US20%

Europe 11%

Other 1%

TM

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

fo

p. 12

Tokyo, JapanJanuary 29-30, 2013

FALL 2013

FALL 2013Barcelona, SpainMarch 11-13, 2013

Vienna, AustriaNovember 4-6, 2013Stockholm, Sweden

May 22-23, 2013

Philadelphia, PAFALL 2013

San Francisco, CAOctober 8-9, 2013

New York, NYFebruary 11-12, 2013

San Diego, CAMarch 25-27, 2013

San Francisco, CAOctober 7, 2013

Chicago, IL April 22-25, 2013

FALL 2013 Montreal, CanadaJune 16-19, 2013

Conference Includes:

• Food Production and Technologies• Animal and Human Health Technologies• Animal Care and Use in Research• Impacts of Biotechnology on Trade• Regulation of GE Animals• Pipeline of International Animal

Biotechnology Products• Training on Communications to

Lay Audiences• Financing Research Opportunities.

LivestockBiotech Summit

Conference Size 200

Developing Global Solutions Through Animal BiotechA focused meeting on the genetic engineering of agricultural animals including benefits, research and development, regulatory systems, and challenges to advancing health, food and industrial applications of animal biotechnology.

COMING 2014!

For more info, contact Natalie Shuster, [email protected]

bio.org/events bio.org/sponsor 202.449.6381

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

fo

BIO

International Convention B

usiness Developm

ent & Investor Industrial &

Environmental Intellectual P

roperty Food & A

griculture Sponsorship Info

p. 18 p. 19

The World’s Largest Industrial Biotech EventFor the past decade, the World Congress had created a unique forum for business executives, government officials, academic researchers and industry leaders to share the latest advances in renewable chemicals, advanced biofuels, enzymes, biopolymers, food ingredients and more.

Features breakout tracks, plenary sessions, workshops, Poster Session & Reception, Clean Tech Investor Sessions, Exhibit Hall, and BIO One-on-One PartneringTM.

For more info, contact Jimmy Wydick, [email protected]

Montreal, Canada: June 16-19, 2013

Where “East Meets West”in Industrial Biotechnology The original conference dedicated solely to the growth of the industrial biotechnology and bioenergy sectors in North America and the Asia-Pacific region.

Programs highlight the latest in advanced biofuels, algae, biomass production, biopolymers , bioplastics, dedicated energy crops, renewable chemicals, marine bio-resources and synthetic biology.

For more info, contact Jimmy Wydick, [email protected]

FALL 2013

Conference Size 1,000+


C-Level Executives 140+

Countries 37


Countries 25+

Attendees By Region

Biotech33%

Pharma 10%

North America- Canada 13%

South America 5%

Asia 10%

Europe 16%

Bringing together delegates from:

Australia MalaysiaCanada New ZealandChina ThailandIndia The United StatesJapan And more

North America-US56%

2013 Events

Navigate our event portfolio.Mark your business calendar.Map out your success.

http://bit.ly/BIOcon

http://bit.ly/BIOlnkdin

twitter.com/IAmBiotech

facebook.com/IAmBiotech

youtube.com/biochannel

bio.org202.449.6381 < < < <

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 20 p. 21

The BIO Technology Transfer Symposium is in its third year and is free to attend. The Symposium brings together investors, academic technology transfer office representatives, and licensing professionals of biotech and pharma companies to discuss the most relevant early-stage university/industry collaborations and policy issues.

The BIO IP Counsels Committee Conferences are must-attend events for the in-house IP counsel of biotech and pharma companies. The fun evening events provide a relaxed atmosphere to encourage discussion and provoke thought on timely industry issues. Join us at our next meeting and see why attendees keep coming back.

Conference Size

90 attendees

Past USPTO speakers include:

Raymond Chen Deputy General Counsel for IP & Solicitor

Robert Stoll Commissioner of Patents Janet Gongola Associate Solicitor

“I have been attending the BIO IPCC conference for the past 6 years and it’s an invaluable way to keep up with this ever-evolving field. The sessions are relevant, designed to provide in-depth analysis, and encourage informal discussion of current IP topics. It’s the one conference I try not to miss.” — Claire Vasios, Alkermes

Vice President, Intellectual Property

Education & Networking Opportunities for the In-House IP Counsel

San Diego, CA: March 25-27, 2013 Philadelphia, PA: Fall 2013


Promoting Public-Private Collaborations for Innovation

Conference Size

60 attendees

San Francisco, CA: October 7, 2013


Past participants have included:

National Institutes of HealthOffice of Innovation and Entrepreneurship, Department of CommerceUniversities Allied for Essential MedicinesThe Wallace H. Coulter FoundationUniversity of VirginiaUniversity of California, San Francisco

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

foB

IO International C


evelopment &



Agriculture S

ponsorship Info

p. 22 p. 23

Types of Sponsorships Networking Receptions

Branding Opportunities

Plenary Sessions

Speaking Opportunities

Dedicated Partnering Space

Educational Sessions

Advocacy Events

Workshops

Why Sponsor a BIO Event? Meet new business partners

Spotlight important initiatives

Enhance customer relationships

Elevate company profile to the media

Increase brand exposure

Reinforce your position as a thought leader

Highlight key executives

For more information contact [email protected] or call 202.449.6381

“It’s a unique opportunity to interact with scientists and companies, to partner, share ideas and advance our goals.”

— Deborah Dunsire, MD President & Chief Executive Officer Millennium: The Takeda Oncology Company

BIO

Inte

rnat

iona

l Con

vent

ion

Bus

ines

s D

evel

opm

ent &

Inve

stor

Ind

ustr

ial &

Env

iron

men

tal

Inte

llect

ual

Pro

pert

y F

ood

& A

gric

ultu

re S

pons

orsh

ip In

fo

p. 24

Double Helix Sponsors

Helix Sponsors

For more information contact [email protected] or call 202.449.6381

as of July 1, 2012

Imagine a world where

breakthrough medicines

save millions of people.

Where food is more

healthful and plentiful.

Where fuel alternatives

power our lives in cleaner,

more efficient ways.

The innovations we are

exploring today will help

deliver the promises

of tomorrow.

We pave the way for the

industry and help unleash

the promise of biotechnology.

We are BIO. Join us.

table of contents - bio · the bio ip counsels committee conferences are must-attend events for the...

Documents